GLP-1 receptor agonists for obesity: eligibility across 99 countries

The Lancet Diabetes & Endocrinology 2026 Open access

Read full text
Authors: Sang Gune K Yoo, Felix Teufel, Michaela Theilmann, Yajuan Si, Elhadji Amadou Touré, Krishna Kumar Aryal, Till Bärnighausen, Abdul Bait, Marta Barreto, Pascal Bovet, Luisa C C Brant, Sarah Cuschieri
+35 more A. Damasceno, Farshad Farzadfar, Asher Fawwad, Pascal Geldsetzer, Ian R Hambleton, Corine Yessito Houehanou, Christina Howitt, Jutta J⊘rgensen, JP Gonzalez-Rivas, Demetre Labadarios, Maja Marcus, Joao Martins, Omar Mwalim, Ramfis Nieto‐Martínez, Augustine N. Odili, Binur Orazumbekova, Gastón Perman, Sarah Quesnel-Crooks, S Ohadian Moghaddam, Ronel Sewpal, Mafalda Sousa-Uva, Mubarak Ayodeji Sulola, Kavita Venkataraman, Sebastian Vollmer, Sim Xueling, Rifat Atun, JR Banegas, Juan V A Franco, Clare Arnott, Nomathemba Chandiwana, Mark D Huffman, Justine Davies, Mohammed K. Ali, D. Flood, J. Manne-Goehler
DOI: 10.1016/s2213-8587(25)00356-0
Cited by: 11
References: 9

Fields of Study & Subjects

Diabetes Treatment and Management Bariatric Surgery and Outcomes Pharmacology and Obesity Treatment

Publication details

Journal / source
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Volume
14
Issue
2
Pages
105–108
Publication date
9 January 2026
Language
EN